- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01284465
Type 2 Diabetes Self-management Intervention for Low-income Women
A Comprehensive Approach to Type 2 Diabetes Self-management for Low-income Women
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In recent years, the prevalence of diabetes has significantly increased among women and because of the expected fast growth rate of minority populations, the number of women in these groups who will be diagnosed with diabetes is also expected to increase significantly over the coming years. Among women from minority groups diabetes is the fourth leading cause of death while it is the seventh among non-Hispanic White females. Non-compliance to diabetes self-care is a major concern for type 2 diabetic women of racial/ethnic groups because of the existing socio-economic and environmental barriers. Often, these women live in poverty; have less than a high school education as well as language barriers and inadequate health literacy, which further place them at risk for complications, and the daily activities of diabetes self-care are implemented within the context of family responsibilities and patient's priorities.
This study is a 12-month randomized controlled trial designed to compare a lifestyle intervention group (combination group) and a control group (education only group). Participants assigned to either group will receive three group education sessions (baseline, 3 and 6 months) with an emphasis on self-management.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Tennessee
-
Nashville, Tennessee, United States, 37208
- Meharry Medical College
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Low-income women ages 21 and older; With type 2 diabetes ( fasting plasma glucose > 126 mg/dl);
At risk of developing diabetes related complications (treatments goals from The American Diabetes Association Standards of medical care) as defined by:
- HbA1c >8.0 %
- Any of the metabolic clusters such as Pre-prandial plasma glucose > 130 mg/dl; Obesity (BMI >25 kg/m2, or waist circumference >88 cm (>35 in); Hypertension (Systolic >130 and Diastolic > 80 mmHg); Hyperlipidemia (Triglycerides >150 mg/dL; HDL<50 mg/dL; LDL >100 mg/dL)
Exclusion Criteria:
- Participants will be excluded if they are currently pregnant, have conditions (i.e., end stage diagnosis) or behaviors likely to affect conduct of the trial, and unwilling to accept treatment assignment by randomization.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
Education and patient liaison combination
|
Group education sessions with Patient liaison using ecological momentary assessment principles
Other Names:
|
Experimental: Control group
Education only
|
Group education sessions at baseline, 3 and 6 months
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
HbA1c
Time Frame: baseline, 6 and 12 months
|
glycosylated hemoglobin
|
baseline, 6 and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Risk factors for co-morbidity and daily self-management behaviors
Time Frame: baseline, 3, 6, 9 and 12 months
|
|
baseline, 3, 6, 9 and 12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Sylvie A Akohoue, PhD, Meharry Medical College
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 081204AAH231 26
- U54RR026140-01 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes
-
Antonio Di MauroCompletedType-2 DiabetesItaly
-
DiaMedica Therapeutics IncCompletedDiabetes Type 2Netherlands
-
RenJi HospitalUnknownType 2 Diabetes.China
-
University of Erlangen-Nürnberg Medical SchoolCompletedType 2-diabetesGermany
-
Chengdu Brilliant Pharmaceutical Co., Ltd.Not yet recruitingType 2 Diabetes Mellitus
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Xiangya Hospital of Central South UniversityRecruitingType 2 Diabetes MellitusChina
-
University of Alabama at BirminghamCompletedType 2 Diabetes MellitusUnited States
-
Imperial College LondonAstraZeneca; Huma; North West London Collaboration of CCGs (NWL CCGs); Imperial...CompletedType 2 Diabetes MellitusUnited Kingdom
-
Universiti Sains MalaysiaCompleted
Clinical Trials on Education and patient liaison combination
-
University of British ColumbiaBritish Columbia Cancer Agency; Women's Health Research Institute of British...CompletedUterine Cervical Dysplasia | Uterine Cervix CancerCanada
-
Harvard Medical School (HMS and HSDM)National Heart, Lung, and Blood Institute (NHLBI)CompletedHypertension | Diabetes MellitisUnited States
-
University Hospital, MontpellierCompleted
-
Riphah International UniversityCompleted
-
Children's Hospital of PhiladelphiaMidwestern UniversityCompletedInformed Consent | Procedural State Anxiety | Subject's SatisfactionUnited States
-
Icahn School of Medicine at Mount SinaiRecruitingEating DisorderUnited States
-
Chulabhorn HospitalCompletedSurgery | Educational Problems
-
University of VictoriaVancouver FoundationCompletedDiabetes Mellitus, Type 2Canada
-
Oslo University HospitalUnknownHip OsteoarthritisNorway
-
Ullevaal University HospitalUnknownExercise Therapy and Patient Education for Individuals With Hip Osteoarthritis. Long-term Follow-up.Hip OsteoarthritisNorway